Brain MRI Imaging Changes and Associated Factors on Cognition Function in Patients With Premature Ovarian Failure

Premature Ovarian Failure Clinical Trial

Official title:

International Peace Maternity and Child Health Hospital (IPMCH) Affiliated to School of Medicine, Shanghai Jiaotong University, Shanghai, China

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06121388
• Other study ID #: GFY2023007
• Status: Recruiting
• Start date: January 1, 2023
• Est. completion date: December 31, 2025

Study information

• Verified date: November 2023
• Source: International Peace Maternity and Child Health Hospital
• Contact: Dongmei Lai, M.D.
• Phone: 86-021-64070434
• Email: laidongmei[@]hotmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to investigate the brain MRI imaging changes and associated factors on cognition function in patients with premature ovarian failure.

Description:

Premature Ovarian Failure (POF) refers to a disease characterized by amenorrhea, infertility, low estrogen levels, and high gonadotropin concentration in women before the age of 40. In recent years, the incidence has shown a significant increase. The average age of POF in China is 28.9 years old, involving 2 million women of childbearing age. POF patients have significant emotional disorders and cognitive changes, but it is not known whether the structure and function of the POF patients' brain have changed. It is known that the perimenopause (i.e. estrogen decline) may be the early stage of AD. Therefore, this study aims to use brain imaging technology to explore the changes of brain injury in POF patients with the progression of the disease to achieve early assessment of AD in POF patients. The research work of this project is mainly based on multimodal magnetic resonance imaging technology. For the clinical phenomenon of brain dysfunction in POF patients, it analyzes the changes in brain structure and brain function of POF patients for the first time. Using artificial intelligence brain network analysis method, from the perspective of brain structure and brain function, to determine whether there is microstructural transformation of white matter in POF patients and whether it is related to disease progression and serological indicators. Through the implementation of this project, it provides a basis for brain structure and functional changes for the diagnosis and treatment of POF, and provides a basis for large-scale clinical research to guide clinical formulation of reasonable diagnosis and treatment plans and prognosis evaluation.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 31, 2025
• Est. primary completion date: September 1, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

1. Criteria for premature ovarian failure:

1. Subjects must meet all the following criteria to be included in the study:

2. Female, between 18 and 40 years old;

3. FSH = 40U/L on two occasions at least four weeks;

4. Sign informed consent. 2. Criteria for the health control group: According to the case control principle, at the same time, the investigators select women with similar age, BMI, working environment, education level and regular menstrual cycle in our hospital, and conduct endocrine examination (FSH <10U/L) for health examination.

Exclusion Criteria:

1. Pregnancy or lactation;

2. Patients with secondary ovarian insufficiency (such as causes of the hypothalamus);

3. Chromosomal karyotype abnormalities (such as Turner syndrome, brittle X syndrome);

4. Any disease that requires immediate blood transfusion;

5. Abuse of alcohol, drugs or drugs (for example, laxatives)

6. Allergies to MRI contrast agents;

7. Accompanied by metal implants, claustrophobia and other magnetic resonance scanning contraindications;

8. Accompanied by serious brain organic diseases, such as epilepsy, stroke, encephalitis, brain trauma, and so on. Nervous system diseases, such as Parkinson's disease, have other cognitive-impacting diseases, or serious somatic diseases such as malignant tumors, acute heart failure, multi-organ failure, and so on.

Related Conditions & MeSH terms

• Menopause, Premature
• Premature Birth
• Premature Ovarian Failure
• Primary Ovarian Insufficiency

Locations

Country	Name	City	State
China	The International Peace Maternity and Child Health Hospital	Shanghai	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
International Peace Maternity and Child Health Hospital

Country where clinical trial is conducted

China, 

References & Publications (3)

Brown A, Gervais NJ, Rieck J, Almey A, Gravelsins L, Reuben R, Karkaby L, Rajah MN, Grady C, Einstein G. Women's Brain Health: Midlife Ovarian Removal Affects Associative Memory. Mol Neurobiol. 2023 Nov;60(11):6145-6159. doi: 10.1007/s12035-023-03424-6. Epub 2023 Jul 10. — View Citation

Maki PM, Resnick SM. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage. 2001 Oct;14(4):789-801. doi: 10.1006/nimg.2001.0887. — View Citation

Zeydan B, Tosakulwong N, Schwarz CG, Senjem ML, Gunter JL, Reid RI, Gazzuola Rocca L, Lesnick TG, Smith CY, Bailey KR, Lowe VJ, Roberts RO, Jack CR Jr, Petersen RC, Miller VM, Mielke MM, Rocca WA, Kantarci K. Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration. JAMA Neurol. 2019 Jan 1;76(1):95-100. doi: 10.1001/jamaneurol.2018.3057. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Brain structure	Brain structure will be assessed by MRI.	1 year
Secondary	Follicle-stimulating hormone (FSH) serum level	Follicle-stimulating hormone (FSH) serum level will be tested.	1 year
Secondary	Luteinizing hormone (LH) serum level	Luteinizing hormone (LH) serum level will be tested.	1 year
Secondary	Estradiol (E2) serum level	Estradiol (E2) serum level will be tested.	1 year
Secondary	Testosterone (T) serum level	Testosterone (T) serum level will be tested.	1 year
Secondary	Prolactin (PRL) serum level	Prolactin (PRL) serum level will be tested.	1 year
Secondary	Anti-müllerian hormone (AMH) serum level	Anti-müllerian hormone (AMH) serum level will be tested.	1 year